AI assistant
Sending…
RTX Corp — Director's Dealing 2013
Jan 25, 2013
29781_dirs_2013-01-25_a44b860f-369b-41ee-961a-b16f91ca182c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: UNITED TECHNOLOGIES CORP /DE/ (UTX)
CIK: 0000101829
Period of Report: 2013-01-24
Reporting Person: CHENEVERT LOUIS (Director, Chairman & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2013-01-24 | Common Stock | M | 70000.0000 | $46.7600 | Acquired | 452712.0000 | Direct |
| 2013-01-24 | Common Stock | S | 9830.0000 | $88.5227 | Disposed | 442882.0000 | Direct |
| 2013-01-24 | Common Stock | F | 14461.0000 | $0.0000 | Disposed | 428421.0000 | Direct |
| 2013-01-24 | Common Stock | F | 37166.0000 | $0.0000 | Disposed | 391255.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2013-01-24 | Non-Qualified Stock Option (right to buy) | $46.7600 | M | 70000.0000 | Disposed | 2014-01-08 | Common Stock (70000.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock (Career Restricted) | 2400.0000 | Direct |
| Common Stock | 4135.0000 | Indirect |
Footnotes
F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $88.50 to $88.88.565. Upon request, UTC will provide full information as to the shares sold at each separate price.
More from RTX Corp
Regulatory Filings
2026
Jun 1
Declaration of Voting Results & Voting Rights Announcements
2026
May 4
Major Shareholding Notification
2026
Apr 30
Interim / Quarterly Report
2026
Apr 21
Earnings Release
2026
Apr 21
Major Shareholding Notification
2026
Mar 27
Annual Report
2026
Mar 9
Proxy Solicitation & Information Statement
2026
Mar 9
Proxy Solicitation & Information Statement
2026
Mar 9
Regulatory Filings
2026
Mar 5